Statement Of Cash Flows [Abstract]

ERYTECH Pharma S.A. - Filing #880081

Concept 2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
2019-01-01 to
2019-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Adjustments for interest expense
2 073 EUR
2 150 EUR
484,000 EUR
Cash flows from (used in) operations before changes in working capital
49 615 EUR
62 522 EUR
57 040 EUR
Increase (decrease) in working capital
7 153 EUR
10 802 EUR
13 730 EUR
Adjustments for decrease (increase) in trade and other receivables
8,000 EUR
33,000 EUR
7,000 EUR
Adjustments for increase (decrease) in trade and other payables
6 477 EUR
6 913 EUR
5 993 EUR
Adjustments for decrease (increase) in other current assets
94,000 EUR
2 829 EUR
6 150 EUR
Adjustments for increase (decrease) in other current liabilities
574,000 EUR
669,000 EUR
556,000 EUR
Adjustments for gains (losses) on change in fair value of derivatives
1 175 EUR
652,000 EUR
EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.